Novo Nordisk A/S ADR buy StockNews.com
Start price
21.12.24
/
50%
€84.00
Target price
21.12.25
-
Performance (%)
-50.95%
End price
22.12.25
€41.20
Summary
This prediction ended on 22.12.25 with a price of €41.20. Massive losses of -50.95% were the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Novo Nordisk A/S ADR where he still thinks Novo Nordisk A/S ADR is a Buy. Dividends of €1.10 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -6.415% | -6.415% | -38.614% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Novo Nordisk A/S ADR
Stopped prediction by StockNews_com for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€102.50
14.12.24
14.12.24
-
14.12.25
14.12.25
-58.15%
15.12.25
15.12.25
